Asthma Clinical Trials in Miami, Florida

11 studies are recruiting for asthma in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

   This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Research Site, Miami, Florida

   Locations

   223 in total

   Run by

   AstraZeneca

   See if you can join NCT06932263 on ClinicalTrials.gov

2. A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma

   The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. Th…

   Stage

   Phase 3

   Ages

   12 to 80

   Site

   Innovations Biotech, Miami, Florida

   Locations

   16 in total

   Run by

   Pfizer

   See if you can join NCT07772921 on ClinicalTrials.gov

3. Ventilation and Perfusion in Asthmatics

   Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity …

   Stage

   Phase 4

   Ages

   18 to 75

   Site

   University of Miami - Converge Miami, Miami, Florida

   Run by

   University of Miami

   See if you can join NCT07426458 on ClinicalTrials.gov

4. Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

   This is a global Phase 2 study divided in two parts. Part A is a double-blind, randomized dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivotal trials for efficacy and safety. Part B is a pivotal double-blind, …

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   WB Contracted Clinical Research Site, Miami, Florida

   Locations

   73 in total

   Run by

   Windward Bio

   See if you can join NCT07120503 on ClinicalTrials.gov

5. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

   The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   Research Site, Miami, Florida

   Locations

   155 in total

   Run by

   AstraZeneca

   See if you can join NCT06307665 on ClinicalTrials.gov

6. A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

   The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

   Stage

   Phase 2

   Ages

   4 to 11

   Site

   Research Site, Miami, Florida

   Locations

   44 in total

   Run by

   AstraZeneca

   See if you can join NCT07525375 on ClinicalTrials.gov

7. A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

   The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The…

   Stage

   Not phased

   Ages

   6 and older

   Site

   EMDA Clinical Research - Site Number: 840113, Miami, Florida

   Locations

   71 in total

   Run by

   Sanofi

   See if you can join NCT07556159 on ClinicalTrials.gov

8. A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

   The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   GSK Investigational Site, Miami, Florida

   Locations

   67 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT05757102 on ClinicalTrials.gov

9. A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

   This study aims to generate additional safety data on the propellant component of the reformulated product by comparing metered dose inhaler (MDIs) containing HFA-152a (test) with HFA-134a (reference).

   Stage

   Phase 3

   Ages

   18 and older

   Site

   GSK Investigational Site, Miami, Florida

   Locations

   18 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT07645248 on ClinicalTrials.gov

10. ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

    This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants w…

    Stage

    Phase 2

    Ages

    18 to 75

    Site

    Enveda Investigative Site, Miami, Florida

    Locations

    20 in total

    Run by

    Enveda Therapeutics

    See if you can join NCT07301255 on ClinicalTrials.gov

11. A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

    The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).

    Stage

    Phase 3

    Ages

    12 and older

    Site

    GSK Investigational Site, Miami, Florida

    Locations

    17 in total

    Run by

    GlaxoSmithKline

    See if you can join NCT07456033 on ClinicalTrials.gov